Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant vs Ondansetron for PONV in Craniotomy
NCT00734929Phase 4Completed
- Sponsor
- Duke University
- Start
- Sep 2007
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of aprepitant in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Duke University. Primary endpoint: Cumulative Incidence of Emesis at 48 hours. Started Sep 2007; status: completed.
02
Drugs
aprepitant
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT00734929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00734929.